MREO - Mereo Bio completes $70M private placement; advances etigilimab into Phase 1b study June, 04 2020 09:50 AM Mereo BioPharma Group Mereo BioPharma (MREO +56.9%) has completed $70M (£56M) private placement (the “Fundraising”).More news on: Mereo BioPharma Group plc, Healthcare stocks news, Stocks on the move, Read more ...